$QDEL QUIDEL CORP /DE/ Insiders
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in QUIDEL CORP /DE/.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of current and past insiders in QUIDEL CORP /DE/. Find out how many shares they currently own, their value and whether they buy or sell their shares.
QUIDEL CORP /DE/ Insiders
| Name | Position | Total Shares | Current Value ($) | Last 3 Months | Buy / Sell | Last Transaction | |
|---|---|---|---|---|---|---|---|
| Abney Michael Donald Jr. | SVP - N.A. Sales & Distrib. | 9,604 | 190,831 | Feb 02 2021 | |||
| BORKAR RATAN S | SVP, Intl Comm Operations | 1,558 | 30,957 | Jan 13 2021 | |||
| Brown Thomas D | Director | 62,039 | 1,232,715 | Feb 26 2019 | |||
| Brown Thomas D | Director | 19,399 | 385,458 | Nov 12 2014 | |||
| BRYANT DOUGLAS C | President & CEO | 495,807 | 9,851,685 | Feb 22 2021 | |||
| BRYANT DOUGLAS C | President & CEO | 203,481 | 4,043,167 | Mar 04 2014 | |||
| BRYANT DOUGLAS C | President & CEO | 223,481 | 4,440,567 | Feb 13 2015 | |||
| BUECHLER KENNETH F | Director | 60,864 | 1,209,368 | May 20 2021 | |||
| BUECHLER KENNETH F | Director | 9,372 | 186,222 | May 19 2014 | |||
| BUECHLER KENNETH F | Director | 0 | 0 | Nov 12 2014 | |||
| Bujarski Robert Joseph | Chief Operating Officer | 22,191 | 440,935 | Feb 19 2021 | |||
| Bujarski Robert Joseph | SVP, Bus Dev & Gen Counsel | 0 | 0 | Feb 13 2015 | |||
| DAMMEYER RODNEY F | Director | 42,769 | 849,820 | May 09 2016 | |||
| DAMMEYER RODNEY F | Director | 3,906 | 77,612 | Nov 06 2014 | |||
| Dammeyer Rodney F | Director | 0 | 0 | Nov 12 2014 | |||
| DE BRUIN ANDRE | Director | 23,300 | 462,971 | Apr 08 2004 | |||
| Ferenczy William J. | SVP, Cardio/Metabolic Unit | 6,127 | 121,743 | May 04 2021 | |||
| Foley Thomas James | Chief Technical Officer | 60,000 | 1,192,200 | May 20 2005 | |||
| Foley Thomas James | Chief Technical Officer | 44,744 | 889,063 | May 27 2009 | |||
| GIBSON KAREN | SVP, Digital Health | 7,832 | 155,622 | Feb 19 2021 | |||
| GLAZE THOMAS A | Director | 14,930 | 296,659 | Nov 23 2005 | |||
| HARRINGTON DOUGLAS S | Director | 14,930 | 296,659 | May 09 2007 | |||
| HEINDEL MATTHEW T | Sr. VP - Global Sales & Mrktg | 8,170 | 162,338 | May 12 2004 | |||
| Hodges Michelle A. | SVP, General Counsel | 0 | 0 | Jun 16 2021 | |||
| KAY S WAYNE | President & CEO | 21,510 | 427,404 | May 12 2004 | |||
| Kroll Werner | SVP, R&D | 21,822 | 433,603 | Feb 24 2021 | |||
| LANDERS PAUL E | Sr. VP - Finance | 91,455 | 1,817,211 | Mar 29 2007 | |||
| Mason Caren L | President and CEO | 155,000 | 3,079,850 | May 20 2005 | |||
| Mason Caren L | President and CEO | 199,952 | 3,973,046 | Oct 30 2008 | |||
| McLeod Scot M | SVP - Operations | 34,486 | 685,237 | Jan 22 2013 | |||
| Michael Edward L | Director | 7,474 | 148,508 | May 14 2021 | |||
| ORDONEZ KATHY | Director | 2,896 | 57,544 | May 14 2021 | |||
| PAIZ MARK | Senior Vice President | 1,251 | 24,857 | Mar 09 2004 | |||
| PAIZ MARK | Chief Operating Officer | 80,682 | 1,603,151 | Jun 21 2007 | |||
| POLAN MARY LAKE PH D | Director | 25,369 | 504,082 | May 14 2021 | |||
| POLAN MARY LAKE PH D | Director | 34,930 | 694,059 | May 09 2007 | |||
| POLAN MARY LAKE PH D | Director | 20,501 | 407,355 | May 07 2014 | |||
| POLAN MARY LAKE PH D | Director | 18,501 | 367,615 | Nov 18 2014 | |||
| PULIDO MARK | Director | 35,947 | 714,267 | Aug 19 2015 | |||
| RADAK JOHN MATTHEW | Chief Financial Officer | 0 | 0 | Apr 09 2008 | |||
| RADAK JOHN MATTHEW | Chief Financial Officer | 20,927 | 415,819 | Mar 04 2011 | |||
| Ranalli Tamara A. | SVP, Molecular Bus. Unit | 11,559 | 229,677 | Feb 19 2021 | |||
| RHOADS ANN D | Director | 624 | 12,399 | May 14 2021 | |||
| Russell Edward Keith | SVP, Business Development | 26,584 | 528,224 | Feb 19 2021 | |||
| Scholl David R. | Senior Vice President | 1,429 | 28,394 | Mar 04 2011 | |||
| SCHULER JACK W | Director | 3,103,249 | 61,661,558 | May 18 2020 | |||
| SCHULER JACK W | Director | 0 | 0 | Nov 18 2014 | |||
| SCHULER JACK W | Director | 3,354,207 | 66,648,093 | Dec 24 2013 | |||
| SLACIK CHARLES P | Director | 12,255 | 243,507 | May 14 2021 | |||
| SMITS MARK W | SVP-Commercial Operations | 9,608 | 190,911 | Jun 02 2015 | |||
| SMITS MARK W | SVP-Commercial Operations | 9,136 | 181,532 | Feb 26 2014 | |||
| SMITS MARK W | SVP-Commercial Operations | 0 | 0 | Feb 09 2015 | |||
| Stenzel Timothy Todd | Chief Science Officer | 18,016 | 357,978 | Mar 04 2014 | |||
| STEWARD RANDALL J | Chief Financial Officer | 15,113 | 300,295 | Apr 01 2021 | |||
| STEWARD RANDALL J | Chief Financial Officer | 0 | 0 | Mar 04 2014 | |||
| STEWARD RANDALL J | Chief Financial Officer | 0 | 0 | Feb 09 2015 | |||
| Strobeck Matthew | Director | 4,909 | 97,542 | May 14 2021 | |||
| TAMERIUS JOHN | SVP, Strat & Ext Affairs | 25,783 | 512,308 | Feb 08 2017 | |||
| TAMERIUS JOHN | SVP - Clinical/Reg Affairs | 30,766 | 611,320 | Jun 26 2014 | |||
| TAMERIUS JOHN | SVP - Clinical/Reg Affairs | 15,766 | 313,270 | Feb 09 2015 | |||
| Tarbox Richard C III | Sr. VP - Corporate Development | 15,317 | 304,349 | Oct 23 2008 | |||
| WATTLETON FAYE | Director | 14,930 | 296,659 | Mar 01 2006 | |||
| WIDDER KENNETH J | Director | 16,032 | 318,556 | May 18 2021 | |||
| Wilkins Joseph D Jr. | Director | 289 | 5,742 | May 20 2021 |